Cargando…
Harmonization of the intracellular cytokine staining assay
Active immunotherapy for cancer is an accepted treatment modality aiming to reinforce the T-cell response to cancer. T-cell reactivity is measured by various assays and used to guide the clinical development of immunotherapeutics. However, data obtained across different institutions may vary substan...
Autores principales: | Welters, Marij J. P., Gouttefangeas, Cécile, Ramwadhdoebe, Tamara H., Letsch, Anne, Ottensmeier, Christian H., Britten, Cedrik M., van der Burg, Sjoerd H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378841/ https://www.ncbi.nlm.nih.gov/pubmed/22714399 http://dx.doi.org/10.1007/s00262-012-1282-9 |
Ejemplares similares
-
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
por: Mandruzzato, Susanna, et al.
Publicado: (2016) -
A framework for T cell assays
por: Britten, Cedrik M., et al.
Publicado: (2015) -
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study
por: Singh, Satwinder Kaur, et al.
Publicado: (2012) -
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols
por: Filbert, Helene, et al.
Publicado: (2012) -
Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)